Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

ARDS


Top 10 Correlated ETFs

ARDS


Top 10 Correlated Stocks

ARDS


In the News

06:48 03 Oct 2022 ARDS

Aridis Pharmaceuticals (ARDS) Reports Q2 Loss, Misses Revenue Estimates

Aridis Pharmaceuticals (ARDS) delivered earnings and revenue surprises of -650% and 97.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

11:31 03 Oct 2022 ARDS

Here's Why Aridis Pharmaceuticals (ARDS) Looks Ripe for Bottom Fishing

Aridis Pharmaceuticals (ARDS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

06:48 03 Oct 2022 ARDS

Aridis Pharmaceuticals (ARDS) Reports Q1 Loss, Lags Revenue Estimates

Aridis Pharmaceuticals (ARDS) delivered earnings and revenue surprises of 13.73% and 40.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

02:41 03 Oct 2022 ARDS

Short Squeeze Stocks: ARDS, BBIG and 3 Others Experts Think Are Ready to Pop

As far as short squeeze stocks go, these five companies top the list in terms of both short interest and borrow fee rates right now. The post Short Squeeze Stocks: ARDS, BBIG and 3 Others Experts Think Are Ready to Pop appeared first on InvestorPlace.

10:40 03 Oct 2022 ARDS

5 Short Squeeze Candidate To Watch: Aridis Pharmaceuticals Tops List, EVgo, Indonesia Energy Corp And More

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.

08:11 03 Oct 2022 ARDS

4 Short Squeeze Penny Stocks To Buy For Under $5 Right Now

Are these short squeeze penny stocks on our watch list right now? The post 4 Short Squeeze Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

11:51 03 Oct 2022 ARDS

Aridis Pharmaceuticals Stock (ARDS): Why The Price Surged Up Today

The stock price of Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) increased by over 30% during intraday trading today. This is why it happened.

11:25 03 Oct 2022 ARDS

4 Penny Stocks Up Big With The Stock Market Down Today; Time To Buy?

Thanks to continued fear and uncertainty, the stock market is down again… The post 4 Penny Stocks Up Big With The Stock Market Down Today; Time To Buy? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

11:30 03 Oct 2022 ARDS

Can These Penny Stocks Climb This Week? 4 To Watch Right Now

Are these penny stocks on your watchlist for next week? The post Can These Penny Stocks Climb This Week?

09:43 03 Oct 2022 ARDS

3 Penny Stocks That Exploded in Premarket Trading Today

These penny stocks climbed during premarket trading today, here's why The post 3 Penny Stocks That Exploded in Premarket Trading Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Financial details

Company Rating
Neutral
Market Cap
16.46M
Income
-25.97M
Revenue
862K
Book val./share
-1.58
Cash/share
0.36
Dividend
-
Dividend %
-
Employees
34
Optionable
No
Shortable
Yes
Earnings
08 Nov 2022
P/E
-0.63
Forward P/E
-
PEG
-0.14
P/S
19.1
P/B
-0.59
P/C
2.58
P/FCF
-3.13
Quick Ratio
0.25
Current Ratio
0.41
Debt / Equity
-0.06
LT Debt / Equity
-0.06
-
-
EPS (TTM)
-3.54
EPS next Y
-
EPS next Q
-
EPS this Y
-98.89%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-62.16%
Revenue last 5Y
12.29%
Revenue Q/Q
-
EPS Q/Q
2.27%
-
-
-
-
SMA20
-30.07%
SMA50
-6.96%
SMA100
-8.55%
Inst Own
10.56%
Inst Trans
-5.08%
ROA
-156%
ROE
156%
ROC
3.15%
Gross Margin
66%
Oper. Margin
-5355%
Profit Margin
-3013%
Payout
-
Shs Outstand
17.7M
Shs Float
13.44M
-
-
-
-
Target Price
-
52W Range
0.68-4.34
52W High
-
52W Low
-
RSI
33.89
Rel Volume
0.61
Avg Volume
197.5K
Volume
121.41K
Perf Week
-36.73%
Perf Month
-50%
Perf Quarter
-37.58%
Perf Half Y
-45.29%
-
-
-
-
Beta
1.25329
-
-
Volatility
0.18%, 0.32%
Prev Close
3.33%
Price
0.93
Change
12.71%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
0.88000.17
Net income per share
-7.0200-4.71
Operating cash flow per share
-7.71-0.96-2.230
Free cash flow per share
-7.93-0.99-2.270
Cash per share
7.72.470.92.18
Book value per share
8.360.43-0.95-1.54
Tangible book value per share
8.350.43-1.07-1.54
Share holders equity per share
8.360.43-0.95-1.54
Interest debt per share
0.1300.050.03
Market cap
28.79M59.97M64.36M17.97M
Enterprise value
4.55M39.07M56.57M-2.02M
P/E ratio
-1.300-0.42
Price to sales ratio
10.440011.71
POCF ratio
-1.19-7.35-3.14-783.52K
PFCF ratio
-1.15-7.2-3.09-765.82K
P/B Ratio
1.0916.49-7.41-1.27
PTB ratio
1.0916.49-7.41-1.27
EV to sales
1.6500-1.31
Enterprise value over EBITDA
-0.21000.05
EV to operating cash flow
-0.19-4.79-2.7687.86K
EV to free cash flow
-0.18-4.69-2.7185.88K
Earnings yield
-0.7700-2.4
Free cash flow yield
-0.87-0.14-0.320
Debt to equity
0000
Debt to assets
0.170.871.71.53
Net debt to EBITDA
1.13000.47
Current ratio
5.351.340.570.8
Interest coverage
-57.4200-178.41
Income quality
1.1000
Dividend Yield
0000
Payout ratio
0000
Sales general and administrative to revenue
1.41004.76
Research and developement to revenue
8.340024.71
Intangibles to total assets
0000
Capex to operating cash flow
0.030.020.020.02
Capex to revenue
-0.25000
Capex to depreciation
-2.39-0.51-1.09-1.22
Stock based compensation to revenue
0.6000
Graham number
36.360012.77
ROIC
-0.92-3.372.676.67
Return on tangible assets
-0.700-1.61
Graham Net
6.41-0.23-1.7-2.26
Working capital
23.05M6.51M-9.69M-6.55M
Tangible asset value
26.28M3.6M-9.79M-14.13M
Net current asset value
23.05M1.51M-11.04M-14.11M
Invested capital
00-0.050
Average receivables
0000
Average payables
2.11M1.82M1.89M3.56M
Average inventory
0000
Days sales outstanding
219.770056.36
Days payables outstanding
0000
Days of inventory on hand
0000
Receivables turnover
1.66006.48
Payables turnover
0000
Inventory turnover
0000
ROE
-0.84003.06
Capex per share
-0.22-0.02-0.040

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
Revenue per share
000.0400.02
Net income per share
00-0.71-0.44-0.45
Operating cash flow per share
-0.59-0.691.32-0.57-0.35
Free cash flow per share
-0.6-0.71.36-0.58-0.35
Cash per share
0.321.461.380.70.36
Book value per share
-1.2-0.33-0.97-1.15-1.58
Tangible book value per share
-1.2-0.34-0.97-1.15-1.58
Share holders equity per share
-1.2-0.33-0.97-1.15-1.58
Interest debt per share
000.020.730.12
Market cap
83.13M45.83M33.78M31.15M19.47M
Enterprise value
79.54M27.61M13.8M31.67M15.23M
P/E ratio
00-0.83-1-0.61
Price to sales ratio
0059.27066.68
POCF ratio
-12.58-5.331.76-3.06-3.17
PFCF ratio
-12.35-5.261.71-3.06-3.17
P/B Ratio
-6.16-11.03-2.39-1.53-0.7
PTB ratio
-6.16-11.03-2.39-1.53-0.7
EV to sales
0024.21052.17
Enterprise value over EBITDA
00-1.34-4.34-2
EV to operating cash flow
-12.04-3.210.72-3.11-2.48
EV to free cash flow
-11.82-3.170.7-3.11-2.48
Earnings yield
00-0.3-0.25-0.41
Free cash flow yield
-0.08-0.190.59-0.33-0.32
Debt to equity
000-0.61-0.06
Debt to assets
2.181.161.531.862.67
Net debt to EBITDA
001.95-0.070.56
Current ratio
0.380.820.80.640.41
Interest coverage
00-40.690-967.13
Income quality
00-1.881.310.77
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
003.4205.76
Research and developement to revenue
0015.07021.74
Intangibles to total assets
00000
Capex to operating cash flow
0.020.010.0300
Capex to revenue
001.010-0.04
Capex to depreciation
-1.33-1.21-2.06-0.16-0.09
Stock based compensation to revenue
00-2.9801.18
Graham number
003.933.374
ROIC
0.517.51.521.030.53
Return on tangible assets
00-0.38-0.33-0.48
Graham Net
-1.89-0.89-1.43-1.78-2.1
Working capital
-14.74M-5.31M-6.55M-11.25M-18.42M
Tangible asset value
-13.51M-4.18M-14.13M-20.43M-27.95M
Net current asset value
-15.94M-6.66M-14.11M-24.46M-31.71M
Invested capital
000-0.64-0.07
Average receivables
266K808.5K316K395K992K
Average payables
2.75M2.84M4.14M3.03M2.79M
Average inventory
00000
Days sales outstanding
0037.420489.76
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
002.4100.18
Payables turnover
00000
Inventory turnover
00000
ROE
000.720.380.29
Capex per share
-0.01-0.010.0400

Frequently Asked Questions

What is Aridis Pharmaceuticals, Inc. stock symbol ?

Aridis Pharmaceuticals, Inc. is a US stock , located in San jose of California and trading under the symbol ARDS

What is Aridis Pharmaceuticals, Inc. stock quote today ?

Aridis Pharmaceuticals, Inc. stock price is $0.93 today.

Is Aridis Pharmaceuticals, Inc. stock public?

Yes, Aridis Pharmaceuticals, Inc. is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap